Register for email alerts and news feeds:
This journal | BMJ Group
rss
Gut 2005;54:575-578; doi:10.1136/gut.2004.048074
Copyright © 2005 BMJ Publishing Group Ltd & British Society of Gastroenterology.
Gut 2005;54:575-578
© 2005 by BMJ Publishing Group Ltd & British Society of Gastroenterology

COMMENTARY

Gall stones

Increased deoxycholic acid absorption and gall stones in acromegalic patients treated with octreotide: more evidence for a connection between slow transit constipation and gall stones

A F Hofmann

Correspondence to:
Correspondence to:
Professor A F Hofmann
Department of Medicine, MC 0813, University of California, San Diego, La Jolla CA 92093-0813; ahofmann@ucsd.edu


Acromegalic patients treated with octreotide have prolonged colonic transit, increased bacterial formation, and subsequent absorption of deoxycholic acid that is indicated by an increased proportion of deoxycholic acid in plasma bile acids. Enrichment of deoxycholic acid in the circulating bile acid pool leads to supersaturated bile and cholesterol gall stones.

Keywords: octreotide; intestinal transit; bile acid; metabolising enzymes; deoxycholic acid; acromegaly

The first 150 words of the full text of this article appear below.

Thomas and colleagues,1 in this issue of Gut, extend previous work from the laboratory of R Hermon Dowling by showing that acromegalic patients treated with octreotide have an increase in faecal anaerobic bacteria that convert cholic acid, the major primary bile acid in humans, to deoxycholic acid, the major secondary bile acid (see page 630). The paper also confirms previous reports from the Dowling laboratory2,3 that octreotide treatment increases colonic transit time in acromegalic patients. In addition, the paper of Thomas et al shows that octreotide treatment results in enrichment of deoxycholic acid in fasting state plasma bile acids.

The present paper is the 11th and could well be the last in a series of papers spanning more than a decade from the Dowling laboratory that have dealt with the pathogenesis of gall stones in acromegalic patients treated with octreotide, a potent somatostatin agonist. Octreotide . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

Octreotide induced prolongation of colonic transit increases faecal anaerobic bacteria, bile acid metabolising enzymes, and serum deoxycholic acid in patients with acromegaly
L A Thomas, M J Veysey, G M Murphy, D Russell-Jones, G L French, J A H Wass, and R H Dowling
Gut 2005 54: 630-635. [Abstract] [Full Text] [PDF]

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Cardiology Jobs

Gastroenterology Jobs